Latest News in the pharma Industry

All

Cambrex invests $24 million in new HPAPI manufacturing capacity at its Charles City, Iowa facility

Cambrex invests $24 million in new HPAPI manufacturing capacity at its Charles City, Iowa facility

8 Aug 2017

Project also includes reconfigure the existing small-scale manufacturing area providing a single high-containment building to support early-stage development and manufacturing.

Read more 
EIB backs German cancer therapy developer MagForce with up to EUR 35m

EIB backs German cancer therapy developer MagForce with up to EUR 35m

8 Aug 2017

The company's NanoTherm therapy makes it possible to combat the tumour from within, while sparing surrounding healthy tissue.

Read more 
Sanner invests in Bensheim production facility

Sanner invests in Bensheim production facility

8 Aug 2017

14 new injection-molding machines and significant increase in efficiency and energy savings.

Read more 
Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks

Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks

8 Aug 2017

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought in a lawsuit against Suzhou, China-based Enzy...

Read more 
Impax announces settlement of contract litigation on Opana ER CII Extended-Release tablets

Impax announces settlement of contract litigation on Opana ER CII Extended-Release tablets

7 Aug 2017

Contract dispute relates to an agreement entered into among Endo International, Penwest Pharmaceuticals and Impax.

Read more 
“INSPAIR, A SMART SENSOR FOR INHALERS”

“INSPAIR, A SMART SENSOR FOR INHALERS”

7 Aug 2017

The smart sensor to convert inhalers into connected devices to help patients with Asthma or Chronic Obstructive Pulmonary Diseases (COPD).

Read more 
Mylan receives tentative approval for TLD under PEPFAR

Mylan receives tentative approval for "TLD" under PEPFAR

7 Aug 2017

Mylan's TLD is the first fixed-dose combination of its kind to be offered to patients being treated for HIV/AIDS.

Read more 
NCI study identifies essential genes for cancer immunotherapy

NCI study identifies essential genes for cancer immunotherapy

7 Aug 2017

This knowledge could speed the development of a new category of drugs.

Read more 
New controlled nucleation resource center

New controlled nucleation resource center

7 Aug 2017

SP Scientifc's ControLyo Central is a suite of online resources to help freeze dried parenterals manufacturers.

Read more 
Insanitary conditions bring Isomeric Pharmacy Solutions to a halt

Insanitary conditions bring Isomeric Pharmacy Solutions to a halt

6 Aug 2017

Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions.

Read more 
AbbVie's Mavyret receives FDA approval for the treatment of chronic hepatitis C

AbbVie's Mavyret receives FDA approval for the treatment of chronic hepatitis C

6 Aug 2017

FDA approval is supported by an overall 98% cure rate in patients who received the recommended duration of treatment .

Read more 
Captek Softgel International acquires J+D Labs

Captek Softgel International acquires J+D Labs

6 Aug 2017

J+D Labs’ extensive experience manufacturing a wide-range of softgels, specialized tablets, capsules, and powder formulations complements Captek’s offerings.

Read more